To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine maximum tolerated dose level (MTD) of PEP005
Topical Gel for the treatment of superficial basal cell carcinoma on the trunk